Abstract
Randomized trials have compared a variety of different endovascular therapies for patients with a failing arteriovenous (AV) hemodialysis access. However, many clinically relevant therapies have never been compared head-to-head in clinical trials. In the present network meta-analysis (NMA), we evaluated the relative effectiveness of multiple endovascular therapies to maintain AV hemodialysis access according to all available evidence.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
